GE HealthCare Technologies Inc.
GEHC · XNASCIK 1932393fmd_1W9Q9HREHFBE9NJ45X19K3FKD9Manufacturing · X-Ray Apparatus & Tubes & Related Irradiation ApparatusTemplate: Standard
Coverage: Jan 01, 2021 to Sep 30, 2026, 20 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | 17,585 | 18,341 | 19,552 | 19,672 | 20,625 |
| Gross profit | 7,174 | 7,179 | 7,922 | 8,205 | 8,248 |
| Realized investment gains (losses) | 3 | (31) | 1 | (22) | 112 |
| Research and development | 816 | 1,026 | 1,205 | 1,311 | 1,260 |
| Selling, general and administrative | 3,563 | 3,631 | 4,282 | 4,269 | 4,225 |
| Total operating expenses | 4,379 | 4,657 | 5,487 | 5,580 | 5,485 |
| Operating income | 2,795 | 2,522 | 2,435 | 2,625 | 2,763 |
| Interest expense | 40 | 77 | 542 | 504 | 440 |
| Other non-operating income (expense) | 123 | 62 | 86 | 55 | 157 |
| Income before taxes | 2,875 | 2,512 | 2,361 | 2,581 | 2,768 |
| Income tax expense | 600 | 563 | 743 | 531 | 614 |
| Net income from continuing operations | 2,275 | 1,949 | 1,618 | 2,050 | 2,154 |
| Net income | 2,247 | 1,916 | 1,568 | 1,993 | 2,084 |
| Net income to common shareholders | 2,247 | 1,916 | 1,385 | 1,993 | 2,084 |